Gilead Sciences to buy Ouro Medicines to boost T cell therapy for autoimmune diseases

AI Briefing

• – Gilead Sciences to buy Ouro Medicines to boost T cell therapy for autoimmune diseases
• – Acquisition to add OM336 T cell engager for autoimmune diseases treatment
• – Expansion of T cell therapy capabilities in the fight against autoimmune diseases